GPX4 and cancer: Techniques such as CRISPR-Cas9 and RNAi can be employed to knock out ferroptosis-inhibiting genes like GPX4 or enhance the expression of ferroptosis-promoting genes, such as ACSL4 and SAT1, which facilitate lipid peroxidation in cancer cells.